See every side of every news story
Published loading...Updated

CANDOR Bioscience acquired by Medix Biochemica - Pharmafile

Summary by pharmafile.com
CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier of raw materials for in vitro diagnostic (IVD). This will support the vision from Medix Biochemica to become the first-in-choice partner for raw materials in the IVD industry. Medix Biochemica claim that the acquisition will strengthen its range of materials, […] The post CANDOR Bioscience acquired by Medix Biochemica appeared first on Phar…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmafile.com broke the news in on Friday, January 31, 2025.
Sources are mostly out of (0)